TVTX is currently covered by 11 analysts with an average price target of $59.85. This is a potential upside of $12.85 (27.34%) from yesterday's end of day stock price of $47.
Our record on Travere Therapeutics covers 22 analysts since 2008; 11 cover it today. Of the 195 price targets those analysts set on TVTX, 181 were reached (93%). The highest performance score on Travere Therapeutics belongs to Anupam Rama of JPMorgan: 7.44, with 6 of 6 targets met in 316 days on average. The latest calls: Vamil Divan of Guggenheim cut the target to $78 from $89 with a Buy rating on 4 Nov 2026; Laura Chico of Wedbush raised the target to $76 from $75 with a Buy rating on 22 Sep 2026; Joseph Pantginis of H.C. Wainwright kept the target at $67 with a Buy rating on 22 Sep 2026. Figures as of 18 Nov 2026.
Travere Therapeutics's activity chart (see below) currently has 253 price targets and 205 ratings on display. The stock rating distribution of TVTX is 91.43% BUY and 8.57% HOLD.
Analysts' price targets on this stock were met 94.21% of the time, taking 487.54 days on average.
Highest price target for TVTX is $85, Lowest price target is $38, average price target is $59.85.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 04-Nov-2026. First documented stock forecast 23-Nov-2020.
Currently out of the existing stock ratings of TVTX, 32 are a BUY (91.43%), 3 are a HOLD (8.57%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Sep-2024
$78
$31 (65.96%)
$89
17 days ago
(04-Nov-2026)
11/14 (78.57%)
$25.58 (48.80%)
434
Buy Since 17-Apr-2023
$76
$29 (61.70%)
$75
1 months 30 days ago
(22-Sep-2026)
20/22 (90.91%)
$15.72 (26.08%)
323
Buy Since 01-Jul-2025
$67
$20 (42.55%)
$67
1 months 30 days ago
(22-Sep-2026)
9/10 (90%)
$6.72 (11.15%)
170
Buy Since 16-Feb-2024
$85
$38 (80.85%)
$70
3 months 16 days ago
(05-Aug-2026)
4/6 (66.67%)
$22.24 (35.44%)
98
Buy Since 22-May-2023
$75
$28 (59.57%)
$60
3 months 16 days ago
(05-Aug-2026)
9/10 (90%)
$12.24 (19.50%)
281
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TVTX (Travere Therapeutics)?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?